EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Complete blood count, coagulation biomarkers, and lung function 6 months after critical COVID ‐19

Salla Kattainen iD, Hanna Pitkänen, Jere Reijula, Johanna Hästbacka

Acta Anaesthesiologica Scandinavica · 2024

DOI: 10.1111/aas.14437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2024. Verfasst von Salla Kattainen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Intensive Care, Department of Perioperative and Intensive Care Medicine, University of Helsinki and HUS Helsinki University Hospital, Hel…. Hauptthemen laut MEDLINE: COVID-19, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: State Funding for University-Level Health Research, Government Funding for University-Level Research, The Finnish Blood Disease Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding the recovery of post‐COVID‐19 organ dysfunction is essential. We evaluated coagulation 6 months post‐COVID‐19, examining its recovery and association with lung function.

Methods

Patients treated for COVID‐19 at intensive care units between 3/2020 and 1/2021 were analyzed for complete blood count (CBC) and coagulation biomarkers (prothrombin time activity (%) (PT%), activated partial thromboplastin time (APTT), fibrinogen, coagulation factor VIII (FVIII), antithrombin (AT), and D‐dimer) during the 6 months post‐hospitalization. Results were compared with acute phase values and correlated with pulmonary function tests (PFT), including forced vital capacity (FVC) and hemoglobin‐corrected diffusing capacity percentage of predicted (DLCOc%), recorded 6 months post‐hospitalization. We examined the association between coagulation biomarkers and DLCOc% using linear regression with age, sex, and invasive mechanical ventilation (IMV) duration, and FVIII (correlated with DLCOc%) as covariates.

Results

Most CBCs and coagulation biomarkers had median values within the normal range. However, only 21% (15/70) of patients achieved full normalization of all biomarkers. Compared to acute COVID‐19, hemoglobin, PT%, and AT increased, while leukocytes, fibrinogen, FVIII, and D‐dimer decreased. Despite decreased levels, FVIII remained elevated in 46% (31/68), leukocytes in 26% (18/70), and D‐dimer in 27% (18/67) at 6 months. A weak negative correlation ( r = −0.37, p = .036) was found between DLCOc% and FVIII. Multivariable analysis revealed a weak, independent association between DLCOc% and FVIII. Excluding patients with anticoagulation therapy, FVIII no longer correlated with DLCOc%, while AT showed a moderate correlation with DLCOc%.

Conclusion

Only a few patients had normal CBC and coagulation biomarker values 6 months after critical COVID‐19. A weak negative correlation between DLCOc% and FVIII suggests that deranged coagulation activity may be associated with reduced diffusing capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BiomarkersHumansMaleFemaleMiddle AgedAgedBlood Cell CountRespiratory Function TestsBlood CoagulationFibrin Fibrinogen Degradation ProductsAdultLungBlood Coagulation TestsFibrinogenRespiration, ArtificialFactor VIII

Stichwörter der Autor:innen

COVID‐19PASCcoagulationcritical carelung function

Substanzen

Biomarkersfibrin fragment DFibrin Fibrinogen Degradation ProductsFibrinogenFactor VIII

Autor:innen und Institutionen

  • Division of Intensive Care, Department of Perioperative and Intensive Care Medicine, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
  • Department of Pulmonology, Heart and Lung Center, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
  • Department of Anaesthesia and Intensive Care, Tampere University Hospital, University of Tampere, Tampere, Finland.

ORCID-Profile: Salla Kattainen

Förderung

  • State Funding for University-Level Health Research
  • Government Funding for University-Level Research
  • The Finnish Blood Disease Research Foundation
  • Blood Disease Research Foundation

Zitieren

APA

Kattainen, S., Pitkänen, H., Reijula, J., & Hästbacka, J. (2024). Complete blood count, coagulation biomarkers, and lung function 6 months after critical COVID ‐19. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14437

Vancouver

Kattainen S, Pitkänen H, Reijula J, Hästbacka J. Complete blood count, coagulation biomarkers, and lung function 6 months after critical COVID ‐19. Acta Anaesthesiologica Scandinavica. 2024. doi:10.1111/aas.14437

BibTeX
@article{Kattainen2024,
  author = {Kattainen, Salla and Pitkänen, Hanna and Reijula, Jere and Hästbacka, Johanna},
  title = {Complete blood count, coagulation biomarkers, and lung function 6 months after critical COVID ‐19},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2024},
  doi = {10.1111/aas.14437}
}
Kostenlos starten →